Biotech - Press Releases

Date	Title	Company
21-Nov-2023	Biocomposites expands its product portfolio with the launch of SYNICEMTM spacers in the UK	Biocomposites
21-Nov-2023	Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes	ViCentra B.V.
21-Nov-2023	European Commission Approves pharmaand GmbH’s Rubraca® (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer	pharmaand GmbH
21-Nov-2023	Amerigo Scientific Introduces Hydrazide Gel Kit for High-Yield Protein Purification	Amerigo Scientific
21-Nov-2023	CD Formulation Offers a 10% Discount on All Products and Services as Thanksgiving Greetings for 2023	CD Formulation
21-Nov-2023	This Thanksgiving, Alfa Chemistry Extends Gratitude with Special Offers	Alfa Chemistry
20-Nov-2023	Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment	Landmark medicines
20-Nov-2023	“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential	Inizio
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	bit.bio's new human iPSC-derived microglia, for reproducible, scalable, and faster neurodegenerative and neuroinflammation research and screening	bit.bio
20-Nov-2023	Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6	Omnix Medical
17-Nov-2023	Leading biotech company awarded prestigious Innovate UK grant to expand search for rare disease therapies	SynaptixBio
17-Nov-2023	BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma	BeiGene
17-Nov-2023	Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence	Versameb AG
17-Nov-2023	Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards	Amolyt Pharma
17-Nov-2023	Ori Biotech LEAPs forward toward commercialization in 2024	Ori Biotech
17-Nov-2023	Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors	Myricx Bio
17-Nov-2023	Tessellate BIO, an Emerging Precision Oncology Company Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board	Tessellate BIO
17-Nov-2023	Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis	XBiotech
17-Nov-2023	bioProcessUK to celebrate biotech’s shining stars	The BioIndustry Association (BIA)